Cargando…
Optimization of proton therapy eye-treatment systems toward improved clinical performances
The treatment protocols of cancerous ocular diseases with proton therapy are well established, and dedicated eye-treatment systems can produce the clinical beam properties that meet the peculiar features required by eye-treatment modalities. However, for general-purpose multiroom systems comprising...
Autores principales: | , , , , , , , , , , , |
---|---|
Lenguaje: | eng |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://dx.doi.org/10.1103/PhysRevResearch.4.013114 http://cds.cern.ch/record/2801558 |
_version_ | 1780972701969547264 |
---|---|
author | Gnacadja, Eustache Hernalsteens, Cédric Boogert, Stewart Flandroy, Quentin Fuentes, Carolina Nevay, Laurence J Pauly, Nicolas Ramoisiaux, Eliott Shields, William Tesse, Robin Van Roermund, Raphael Vanwelde, Marion |
author_facet | Gnacadja, Eustache Hernalsteens, Cédric Boogert, Stewart Flandroy, Quentin Fuentes, Carolina Nevay, Laurence J Pauly, Nicolas Ramoisiaux, Eliott Shields, William Tesse, Robin Van Roermund, Raphael Vanwelde, Marion |
author_sort | Gnacadja, Eustache |
collection | CERN |
description | The treatment protocols of cancerous ocular diseases with proton therapy are well established, and dedicated eye-treatment systems can produce the clinical beam properties that meet the peculiar features required by eye-treatment modalities. However, for general-purpose multiroom systems comprising eye-treatment beamlines and nozzles, the design and commissioning procedures must be optimized to achieve the performances of fully dedicated systems in terms of depth-dose distal falloff, lateral penumbra, and dose rate. This paper presents a realistic start-to-end beam transport and particle-matter interactions model of the ion beam applications Proteus® Plus (P+) single-scattering eye-treatment room with Beam Delivery SIMulation (bdsim) using Geant4. The model is used to establish optimization patterns in terms of beam optics to achieve a smaller depth-dose distal falloff than the design baseline while maintaining a nominal dose rate and lateral flatness of the dose deposition profile. An alternative design is proposed to increase the dose rate further by up to a factor 3, allowing for delivering a complete hypofractionated treatment session under 60 s. It uses a beam-stopping device to complement the existing scattering features of the nozzle. An in-depth study of the system is performed using bdsim and the numerical simulations are discussed in detail. |
id | cern-2801558 |
institution | Organización Europea para la Investigación Nuclear |
language | eng |
publishDate | 2022 |
record_format | invenio |
spelling | cern-28015582023-03-30T12:03:42Zdoi:10.1103/PhysRevResearch.4.013114http://cds.cern.ch/record/2801558engGnacadja, EustacheHernalsteens, CédricBoogert, StewartFlandroy, QuentinFuentes, CarolinaNevay, Laurence JPauly, NicolasRamoisiaux, EliottShields, WilliamTesse, RobinVan Roermund, RaphaelVanwelde, MarionOptimization of proton therapy eye-treatment systems toward improved clinical performancesPhysics in GeneralThe treatment protocols of cancerous ocular diseases with proton therapy are well established, and dedicated eye-treatment systems can produce the clinical beam properties that meet the peculiar features required by eye-treatment modalities. However, for general-purpose multiroom systems comprising eye-treatment beamlines and nozzles, the design and commissioning procedures must be optimized to achieve the performances of fully dedicated systems in terms of depth-dose distal falloff, lateral penumbra, and dose rate. This paper presents a realistic start-to-end beam transport and particle-matter interactions model of the ion beam applications Proteus® Plus (P+) single-scattering eye-treatment room with Beam Delivery SIMulation (bdsim) using Geant4. The model is used to establish optimization patterns in terms of beam optics to achieve a smaller depth-dose distal falloff than the design baseline while maintaining a nominal dose rate and lateral flatness of the dose deposition profile. An alternative design is proposed to increase the dose rate further by up to a factor 3, allowing for delivering a complete hypofractionated treatment session under 60 s. It uses a beam-stopping device to complement the existing scattering features of the nozzle. An in-depth study of the system is performed using bdsim and the numerical simulations are discussed in detail.oai:cds.cern.ch:28015582022 |
spellingShingle | Physics in General Gnacadja, Eustache Hernalsteens, Cédric Boogert, Stewart Flandroy, Quentin Fuentes, Carolina Nevay, Laurence J Pauly, Nicolas Ramoisiaux, Eliott Shields, William Tesse, Robin Van Roermund, Raphael Vanwelde, Marion Optimization of proton therapy eye-treatment systems toward improved clinical performances |
title | Optimization of proton therapy eye-treatment systems toward improved clinical performances |
title_full | Optimization of proton therapy eye-treatment systems toward improved clinical performances |
title_fullStr | Optimization of proton therapy eye-treatment systems toward improved clinical performances |
title_full_unstemmed | Optimization of proton therapy eye-treatment systems toward improved clinical performances |
title_short | Optimization of proton therapy eye-treatment systems toward improved clinical performances |
title_sort | optimization of proton therapy eye-treatment systems toward improved clinical performances |
topic | Physics in General |
url | https://dx.doi.org/10.1103/PhysRevResearch.4.013114 http://cds.cern.ch/record/2801558 |
work_keys_str_mv | AT gnacadjaeustache optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT hernalsteenscedric optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT boogertstewart optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT flandroyquentin optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT fuentescarolina optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT nevaylaurencej optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT paulynicolas optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT ramoisiauxeliott optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT shieldswilliam optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT tesserobin optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT vanroermundraphael optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances AT vanweldemarion optimizationofprotontherapyeyetreatmentsystemstowardimprovedclinicalperformances |